enicepatide   Click here for help

GtoPdb Ligand ID: 14700

Synonyms: CT-388 | CT388 | RO-7795068 | RO7795068
Compound class: Peptide
Comment: Enicepatide (CT-388) is a dual GLP-1R and GIPR agonist peptide [2], with signalling bias towards cAMP accumulation (i.e., it has minimal effect on β-arrestin-2 recruitment by either receptor) that limits ligand-induced receptor internalisation [1].
Click here for help
No information available.
Summary of Clinical Use Click here for help
Enicepatide (CT-388) was progressed as a potential anti-obesity therapeutic.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04838405 A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus Phase 1 Interventional Carmot Therapeutics, Inc. 1
NCT07351045 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes Phase 3 Interventional Hoffmann-La Roche
NCT07351058 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes Phase 3 Interventional Hoffmann-La Roche
NCT07670416 A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes Phase 3 Interventional Hoffmann-La Roche